Mohit Vij

Mohit Vij

Auto-generated profile, based on publicly available information

Mohit Vij

School of Pharmaceutical Sciences, Lovely Professional University, Punjab, India

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2013 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Closed access
PDF file
SVShivani Verma
Shivani Verma
ABAnkur Bhardwaj
Ankur Bhardwaj
MVMohit Vij
Mohit Vij
PBPawan Bajpai
Pawan Bajpai
NGNishant Goutam
Nishant Goutam
LKLalit Kumar
Lalit Kumar
The occurrence of topical fungal infections is increasing nowadays. Cutaneous fungal infections like cutaneous candidiasis are more prominent in patients associated with AIDS. Current available strategies for the treatment of cutaneous fungal infections are creams or gels which show various adverse effects on skin along with systemic absorption. These drawbacks can be overcome by using various novel drug delivery systems. So, the present investigation aims at exploring the potential of fatty acid vesicles (ufasomes) for the topical delivery of clotrimazole. Oleic acid was employed as a fatty material for the preparation of vesicles. Clotrimazole-loaded oleic acid vesicles were prepared using a thin film hydration method. Prepared vesicles were characterized for size, size distribution, shape, thermal behaviour (differential scanning calorimetry), in vitro release, in vitro antifungal activity, in vitro skin permeation and retention studies and for in vivo antifungal activity. Transmission electron microscopic (TEM) images confirmed the formation of vesicular dispersion (ufasomes) of clotrimazole. Oleic acid vesicles possessed high drug entrapment (49.5 ± 1.0%) and optimum size (455 ± 22 nm) along with good colloidal characteristics (polydispersity index = 0.210 ± 0.035 & zeta potential = − 22.45 ± 0.25 mV) at 4:6 drug-to-oleic acid ratio. In vitro drug release study showed sustained release of drug from the vesicular dispersion. Skin permeation and skin retention studies suggested accumulation of drug in the epidermal part of the skin. In vivo study confirmed prolonged release of drug from oleic acid vesicle up to five days indicating its usefulness for long-term therapy. So, it can be concluded from the present study that fatty acid vesicle may be a good approach to treat topical fungal infections.

1 June 2024 in Recent Patents on Nanotechnology
Verified
Journal Article
Closed access
PDF file
PWPANKAJ WADHWA
PANKAJ WADHWA
MVMohit Vij
Mohit Vij
NDNeha Dand
Neha Dand
The ever-increasing applications of cyclodextrin and cyclodextrin-based nanosponges in formulation development has gained much attention from researchers towards needed research in this arena. Nanosponges are three-dimensional nanoporous versatile carriers in the pharmaceutical research field because of their capability to encapsulate lipophilic and hydrophilic drugs both in their crystalline structure by inclusion and non-inclusion phenomenon. This review sheds light on the advancements made in this field and the associated patents with regard to their synthesis while zooming in on the utilization of two novel energies (Microwave and ultrasonic) in accomplishing this goal and its future thereof. Microwave and ultrasound-assisted manufacturing of cyclodextrin-based nanosponges (CDNS) has been found superior to conventional heat-dependent methods due to rapid/homogenous heating and fast kinetics, which ultimately provide the final product with high yield and crystallinity relatively rapidly. The review article also defines several facets of microwave and ultrasound-assisted nanosponge synthesis including the synergism of microwave and ultrasonic energy and the theories behind them. This hitherto unexplored microwave-ultrasonic coupling technology could be a future technology to synthesize CD-NS with a better outcome. In the recent past, these novel energy processes have been used successfully in material synthesis at an industrial scale due to their swift and streamlined synthesis attributes. Likewise, these wave-assisted methods have the full potential to materialize the concept of CD-NS from lab scale to industrial scale as a competent and versatile drug carrier, having all the prerequisite characteristics, for commercialization.

30 March 2010 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
HGHarshal Garse
Harshal Garse
MVMohit Vij
Mohit Vij
MYManohar Yamgar
Manohar Yamgar
VKVilasrao Kadam
Vilasrao Kadam
RHRajashree Hirlekar
Rajashree Hirlekar

24 April 2022 in ECS Transactions
Verified
Journal Article
Closed access
MVMohit Vij
Mohit Vij
PWPankaj Wadhwa
Pankaj Wadhwa
Cinnarizine is plagued by low aqueous solubility and thereby poor bioavailability. Thus, it could be a model drug whose bioavailability can be improved by enhancing its solubility. The present study focuses on the fabrication of cyclodextrin-based nanosponges using a microwave-assisted approach. Phase solubility studies were performed to shortlist the cyclodextrin. The manufacturing process was streamlined by applying the 3-factor, 3-level Box-Behnken experimental design to optimize the microwave power level, reaction time, and stirring speed. The batch with the least particle size and highest yield was finalized. The prepared nanosponges were characterized for particle size, polydispersity index, zeta potential, drug loading, entrapment efficiency, and FTIR spectroscopy. The in-vitro drug release showed a drastic improvement in the solubility and release of cinnarizine from the nanosponges as compared to that of the plain drug and drug-cyclodextrin physical mixture. The study proved the suitability of this system for the solubility enhancement of cinnarizine.

1 August 2021 in Recent Innovations in Chemical Engineering
Verified
Journal Article
Closed access
PDF file
MVMohit Vij
Mohit Vij
NDNeha Dand
Neha Dand
PWPANKAJ WADHWA
PANKAJ WADHWA
Metabolism is a cellular process for energy formation from food sources by using a multitude of interdependent pathways with the help of thousands of enzymatic machinery. Encyclopedia of genetics defines metabolic diseases as the inability of metabolism, including improper functioning of enzymes for metabolism of carbohydrates, amino acids derived from proteins, and fatty acids liberated from lipids, respectively. Most of these are typically inherited but a person may remain asymptomatic for years before the disease could get triggered. An interesting characteristic of these diseases is that their occurrence would be considered rare when individual statistics are studied but the same diseases could be considered common when studied in a group of people with unifying genetic features. A few metabolic diseases could be acquired and have their origin in malnutrition such as Kwashiorkor and Marasmus or diseases that could be attributed to endocrinal malfunction of which diabetes mellitus and obesity are classic examples. Treatments for these diseases are as varied as the causes and can range from simple dietary changes to organ transplants. Biopharmaceuticals such as proteins, peptides, as well as antisense oligonucleotides, and deoxyribonucleic acid (DNA) preparations for gene therapy could provide a viable, non-invasive mode to treat most of these inherited diseases whereas nutritional supplements along with herbal and synthetic drugs would be the way to treat the acquired ones. Nevertheless, formulating biopharmaceuticals with excellent efficacy, optimal shelf life and the ability for large scale manufacturing have still eluded the pharmaceutical industry. Nanotechnology can maneuver the structure of original therapeutic materials into a new nano range materials which demonstrate incredible property differences compared to those of original materials. Hence Nanomedicine could be the way forward to deliver a plethora of drugs ranging from biological, herbal, and synthetic nature as compared to traditional methods. A wide spectrum of nanoparticulate based systems such as inorganic particles like quantum dots, dendrimers; polymeric systems utilizing biodegradable polymers of natural or synthetic origin, lipid-based systems like liposomes, solid lipid nanoparticles, etc have been employed successfully in the delivery of the aforementioned classes of drugs. This review will encompass a brief introduction to various metabolic disorders and would focus on the available and possible nano-based treatment options for each of them.